摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(3,8-二氮杂双环[3.2.1]-8-辛基)-1-哌啶羧酸1,1-二甲基乙基酯 | 1120214-86-9

中文名称
4-(3,8-二氮杂双环[3.2.1]-8-辛基)-1-哌啶羧酸1,1-二甲基乙基酯
中文别名
——
英文名称
tert-Butyl 4-(3,8-diazabicyclo[3.2.1]octan-8-yl)piperidine-1-carboxylate
英文别名
——
4-(3,8-二氮杂双环[3.2.1]-8-辛基)-1-哌啶羧酸1,1-二甲基乙基酯化学式
CAS
1120214-86-9
化学式
C16H29N3O2
mdl
——
分子量
295.425
InChiKey
SYHFFGHGMBRCEP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    44.8
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933990090

SDS

SDS:9997b7c04daadafb5113299a47ed5412
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(3,8-二氮杂双环[3.2.1]-8-辛基)-1-哌啶羧酸1,1-二甲基乙基酯二苯氯甲烷 在 sodium carbonate 、 sodium iodide 作用下, 以 乙腈 为溶剂, 以100%的产率得到tert-butyl 4-(3-benzhydryl-3,8-diazabicyclo[3.2.1]octan-8-yl)piperidine-1-carboxylate
    参考文献:
    名称:
    The design and discovery of novel amide CCR5 antagonists
    摘要:
    The synthesis of a range of novel amine-containing structures and their primary potency as inhibitors of HIV-1 fusion via blocking of the CCR5 receptor is described. The development of the medicinal chemistry strategy and SAR's which led to the identification of the piperidine amide compounds 33 and 36 as excellent leads for further evaluation is described, along with key physicochemical data which highlighted their lead potential. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.01.012
  • 作为产物:
    描述:
    tert-butyl 4-(3-benzyl-3,8-diazabicyclo[3.2.1]octan-8-yl)piperidine-1-carboxylate 在 10% Pd/C 、 氢气 作用下, 以 乙醇 为溶剂, 60.0 ℃ 、413.69 kPa 条件下, 以62%的产率得到4-(3,8-二氮杂双环[3.2.1]-8-辛基)-1-哌啶羧酸1,1-二甲基乙基酯
    参考文献:
    名称:
    The design and discovery of novel amide CCR5 antagonists
    摘要:
    The synthesis of a range of novel amine-containing structures and their primary potency as inhibitors of HIV-1 fusion via blocking of the CCR5 receptor is described. The development of the medicinal chemistry strategy and SAR's which led to the identification of the piperidine amide compounds 33 and 36 as excellent leads for further evaluation is described, along with key physicochemical data which highlighted their lead potential. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.01.012
点击查看最新优质反应信息

文献信息

  • The design and discovery of novel amide CCR5 antagonists
    作者:David C. Pryde、Martin Corless、David R. Fenwick、Helen J. Mason、Blanda C. Stammen、Peter T. Stephenson、David Ellis、David Bachelor、David Gordon、Christopher G. Barber、Anthony Wood、Donald S. Middleton、David C. Blakemore、Gemma C. Parsons、Rachel Eastwood、Michelle Y. Platts、Keith Statham、Kerry A. Paradowski、Catherine Burt、Wolfgang Klute
    DOI:10.1016/j.bmcl.2009.01.012
    日期:2009.2
    The synthesis of a range of novel amine-containing structures and their primary potency as inhibitors of HIV-1 fusion via blocking of the CCR5 receptor is described. The development of the medicinal chemistry strategy and SAR's which led to the identification of the piperidine amide compounds 33 and 36 as excellent leads for further evaluation is described, along with key physicochemical data which highlighted their lead potential. (C) 2009 Elsevier Ltd. All rights reserved.
查看更多